Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Supreme Court declines ex-InterMune CEO appeal

This article was originally published in Scrip

Executive Summary

The US Supreme Court on 16 December declined to hear an appeal from Dr Scott Harkonen, the former CEO of InterMune, who was convicted in September 2009 of wire fraud for his role in creating and disseminating an August 2002 press release deemed by federal prosecutors as containing "fraudulent" statements about Actimmune (Interferon gamma-1b), the company's bioengineered form of interferon gamma, a protein that acts as a biologic response modifier through stimulation of the human immune system.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts